相关实验视频

Updated: Jul 9, 2025

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K

在HBV诱导的肝炎中,甲酸共运输多 (NTCP) 的作用:开发新疗法的机会

Zhentao Zhang1, Qi Zhang1, Yiwen Zhang2

  • 1Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, China.

Biochemical pharmacology
|December 4, 2023
PubMed
概括

乙型肝炎病毒 (HBV) 感染依赖NTCP进入细胞. 这份审查详细介绍了NTCP的细节.

关键词:
这是一种抗HBV药物.细胞内存症是指细胞内存症.皮肤表皮生长因子受体.这是HBV HBV.在NTCP中,NTCP是NTCP.这是一种NTCP抑制剂.

更多相关视频

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.4K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.3K

相关概念视频

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
41